223 related articles for article (PubMed ID: 1353431)
1. Gene transfer into hematopoietic stem cells: prospects for human gene therapy.
Einerhand MP; Valerio D
Curr Top Microbiol Immunol; 1992; 177():217-35. PubMed ID: 1353431
[No Abstract] [Full Text] [Related]
2. Gene therapy: a new approach for the treatment of genetic disorders.
Cournoyer D; Scarpa M; Jones SN; Moore KA; Belmont JW; Caskey CT
Clin Pharmacol Ther; 1990 Jan; 47(1):1-11. PubMed ID: 1967233
[No Abstract] [Full Text] [Related]
3. [Gene therapy of primary immunodeficiencies. Present and future].
Serrano F; Laín de Lera T; González MA; García MJ; Abad JL; Bernad A
Sangre (Barc); 1999 Apr; 44(2):143-53. PubMed ID: 10382324
[No Abstract] [Full Text] [Related]
4. Genetic manipulation of hematopoietic stem cells in adenosine deaminase deficiency.
Williams DA; Moritz T
Adv Exp Med Biol; 1994; 370():395-400. PubMed ID: 7660937
[No Abstract] [Full Text] [Related]
5. Successful peripheral T-lymphocyte-directed gene transfer for a patient with severe combined immune deficiency caused by adenosine deaminase deficiency.
Onodera M; Ariga T; Kawamura N; Kobayashi I; Ohtsu M; Yamada M; Tame A; Furuta H; Okano M; Matsumoto S; Kotani H; McGarrity GJ; Blaese RM; Sakiyama Y
Blood; 1998 Jan; 91(1):30-6. PubMed ID: 9414266
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for adenosine deaminase deficiency.
Cappelli B; Aiuti A
Immunol Allergy Clin North Am; 2010 May; 30(2):249-60. PubMed ID: 20493400
[TBL] [Abstract][Full Text] [Related]
7. Prospects for gene therapy of human disease.
Blaese RM; Culver KW
Allergol Immunopathol (Madr); 1991; 19(1):25-8. PubMed ID: 1683140
[No Abstract] [Full Text] [Related]
8. Gene therapy. The best of times, the worst of times.
Anderson WF
Science; 2000 Apr; 288(5466):627-9. PubMed ID: 10799000
[No Abstract] [Full Text] [Related]
9. Gene therapy using hematopoietic stem cells.
Kohn DB
Curr Opin Mol Ther; 1999 Aug; 1(4):437-42. PubMed ID: 11713757
[TBL] [Abstract][Full Text] [Related]
10. Retrovirus mediated gene transfer as therapy for adenosine deaminase (ADA) deficiency.
Ramsey WJ; Mullen CA; Blaese RM
Leukemia; 1995 Oct; 9 Suppl 1():S70. PubMed ID: 7475319
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy for human inherited disorders: techniques and status.
Hoeben RC; Valerio D; van der Eb AJ; van Ormondt H
Crit Rev Oncol Hematol; 1992 Jul; 13(1):33-54. PubMed ID: 1333218
[No Abstract] [Full Text] [Related]
12. Cellular gene therapy.
Lee JH; Klein HG
Hematol Oncol Clin North Am; 1995 Feb; 9(1):91-113. PubMed ID: 7737946
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte gene therapy.
Culver KW; Anderson WF; Blaese RM
Hum Gene Ther; 1991; 2(2):107-9. PubMed ID: 1911929
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy for genetic diseases.
Anderson WF
Hum Gene Ther; 1994 Mar; 5(3):281-2. PubMed ID: 8018743
[No Abstract] [Full Text] [Related]
15. Update on gene therapy for hereditary hematological disorders.
Herzog RW; Arruda VR
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):215-32. PubMed ID: 15030282
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for severe combined immunodeficiencies.
Gaspar HB; Thrasher AJ
Expert Opin Biol Ther; 2005 Sep; 5(9):1175-82. PubMed ID: 16120048
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for ADA-SCID, the first marketing approval of an
Aiuti A; Roncarolo MG; Naldini L
EMBO Mol Med; 2017 Jun; 9(6):737-740. PubMed ID: 28396566
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency: improved retroviral vectors for clinical trials.
Onodera M; Nelson DM; Sakiyama Y; Candotti F; Blaese RM
Acta Haematol; 1999; 101(2):89-96. PubMed ID: 10202239
[TBL] [Abstract][Full Text] [Related]
19. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with CD34+ selected autologous peripheral blood cells transduced with a human ADA gene. Amendment to clinical research project, Project 90-C-195, January 10, 1992.
Blaese RM; Culver KW; Chang L; Anderson WF; Mullen C; Nienhuis A; Carter C; Dunbar C; Leitman S; Berger M
Hum Gene Ther; 1993 Aug; 4(4):521-7. PubMed ID: 7691188
[TBL] [Abstract][Full Text] [Related]
20. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency.
Kohn DB; Weinberg KI; Nolta JA; Heiss LN; Lenarsky C; Crooks GM; Hanley ME; Annett G; Brooks JS; el-Khoureiy A
Nat Med; 1995 Oct; 1(10):1017-23. PubMed ID: 7489356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]